The Impact of Anti-Amyloid Immunotherapies on Stroke Care

被引：3
|
作者：
Bilodeau, Philippe A. [1 ]
Dickson, John R. [2 ]
Kozberg, Mariel G. [2 ,3 ]
机构：
[1] Harvard Med Sch, Massachusetts Gen Hosp, Div Neuroimmunol & Neuroinfect Dis, Boston, MA 02114 USA
[2] Harvard Med Sch, Massachusetts Gen Hosp, MassGeneral Inst Neurodegenerat Dis, 114 16th St, Boston, MA 02129 USA
[3] Harvard Med Sch, Massachusetts Gen Hosp, J Philip Kistler Stroke Res Ctr, Boston, MA 02114 USA
来源：
JOURNAL OF CLINICAL MEDICINE | 2024年 / 13卷 / 05期
关键词：
anti-amyloid immunotherapy; amyloid-related imaging abnormalities; ARIA-E; ARIA-H; cerebral amyloid angiopathy; ischemic stroke; antithrombotics; thrombolytics; ANGIOPATHY-RELATED INFLAMMATION; ATRIAL APPENDAGE CLOSURE; BETA-RELATED ANGIITIS; CORTICAL SUPERFICIAL SIDEROSIS; 2-PHASE; TRIALS; INTRACEREBRAL HEMORRHAGE; IMAGING ABNORMALITIES; ALZHEIMER-DISEASE; CEREBRAL-HEMORRHAGE; BAPINEUZUMAB;
D O I：
10.3390/jcm13051245
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Anti-amyloid immunotherapies have recently emerged as treatments for Alzheimer's disease. While these therapies have demonstrated efficacy in clearing amyloid-beta and slowing cognitive decline, they have also been associated with amyloid-related imaging abnormalities (ARIA) which include both edema (ARIA-E) and hemorrhage (ARIA-H). Given that ARIA have been associated with significant morbidity in cases of antithrombotic or thrombolytic therapy, an understanding of mechanisms of and risk factors for ARIA is of critical importance for stroke care. We discuss the latest data regarding mechanisms of ARIA, including the role of underlying cerebral amyloid angiopathy, and implications for ischemic stroke prevention and management.
引用
收藏
页数：16
相关论文
共 50 条
12345